One person familiar with the matter said there was a meeting between top federal health officials and White House staff on Thursday to discuss the booster issue. In the meeting, the officials warned that more time may be needed before enough data is in to recommend boosters for all adults, the person said.
FDA officials previously tried to get the White House to not put a specific date on when people should expect Covid-19 booster shots, but they did anyway.
“We always said we would follow the science and this is all part of a process that is now underway. We are awaiting a full review and approval by the FDA and a recommendation by the (Advisory Committee on Immunization Practices). When that approval and recommendation are made, we will be ready to implement the plan our nation’s top doctors developed so that we are staying ahead of this virus,” Meagher said in a statement.
The FDA is already evaluating data submitted by Pfizer/BioNTech for approval of a booster dose. Moderna said Wednesday it has started submitting data to the FDA to support giving a booster dose of its vaccine to people six months after their second dose.
The FDA’s Vaccines and Related Biological Products Advisory Committee is scheduled to meet about boosters on September 17.
This is a breaking story and will be updated.